This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

MAG Technique Shows Promise for Gastric Cancer

Comments
Print

OAK BROOK, Ill.—A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

Endoscopic submucosal dissection (ESD) is useful in the en bloc removal of large gastric lesions because it reduces the risk of a local recurrence caused by removing the lesions piecemeal. ESD is a complicated procedure that requires a high level of skill by the endoscopist. The magnetic-anchor-guided endoscopic submucosal dissection (MAG-ESD) technique was developed to facilitate the standard ESD procedure.

The researchers note that to their knowledge, this is the first clinical trial to use MAG-ESD for early gastric cancer in humans. The study appears in the January issue of GIE: Gastrointestinal Endoscopy.

« Previous123456Next »
Comments
comments powered by Disqus